Vivo Opportunity Fund Holdings L.P. 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-15 5:02 pm Purchase | 2023-05-08 | 13G | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings L.P. | 8,418,093 19.990% | 8,418,093 (New Position) | Filing |